Doribax - 2007 FDA approvals

Drug: Doribax (doripenem)
Indication: Urrinary tract infections
Company: Johnson & Johnson
Approval Date: October 12, 2007

Scoop: DORIBAX belongs to a class of antibacterial agents called carbapenems, which are important for treating serious infections caused by Gram-positive and Gram-negative bacteria. The drug is approved for complicated intra-abdominal and complicated urinary tract infections, including pyelonephritis.